Last Updated: November 9, 2026

Patent: 10,287,358

Summary for Patent: 10,287,358

Title:	Antibodies against human CSF-1R and uses thereof
Abstract:	The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
Inventor(s):	Nikolaos Dimoudis, Georg Fertig, Alexander Fidler, Guy Georges, Klaus Kaluza, Martin Lanzendoerfer, Carola Ries, Stefan Seeber, Marlene Thomas
Assignee:	Roche Diagnostics GmbH , Hoffmann La Roche Inc
Application Number:	US16/055,947
Patent Claims:	see list of patent claims

Details for Patent 10,287,358

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Elusys Therapeutics, Inc.	ANTHIM	obiltoxaximab	Injection	125509	March 18, 2016	⤷ Start Trial	2038-08-06
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,287,358

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Argentina	079333	⤷ Start Trial
Australia	2010329934	⤷ Start Trial
Australia	2015213308	⤷ Start Trial
Brazil	112012013717	⤷ Start Trial
Canada	2780692	⤷ Start Trial
Chile	2012001547	⤷ Start Trial
China	102791738	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.